Clinical Research Staffing for Sponsors, Sites and CROs
Coordinators, research nurses, monitors and trial managers, screened for the study tasks an investigator will actually delegate to them.
Can a coordinator you hire on Monday consent a patient on Tuesday?
Clinical research staffing supplies the coordinators, research nurses, monitors, trial managers and regulatory staff that sponsors, research sites and contract research organizations (CROs) need to run studies under Good Clinical Practice. KORE1 fills those seats contract or direct.
Last updated: September 28, 2026
Probably not. Not until the principal investigator has trained them on that protocol and put their name on the site’s delegation log, which can take longer than the offer did. Good hires still start slow. Plan for it.
I’ve spent most of my career recruiting for pharma, and clinical research is the corner of it where a great résumé buys the least on day one. Every study brings its own protocol, its own consent form and its own sponsor’s systems. New ones, every time. That’s the gap a clinical research staffing agency should plan around, so we hire for the study, not the title.
- This desk
- Coordinators, research nurses, clinical research associates (CRAs), trial managers, study start-up and GCP quality staff at sponsors, research sites and CROs.
- Routed elsewhere
- EDC builds and trial systems go to life sciences IT staffing, CLIA lab testing staff to clinical lab staffing, and clinical supply manufacturing to CDMO staffing.
It’s one of the desks inside KORE1’s life sciences staffing group. Our retention figure, 92% at twelve months, counts every one of those desks.
Clinical Research Staffing Starts on the Delegation Log
Every study keeps a record of which trial tasks the investigator has handed to whom. Here’s an illustrative one for a site that just hired a second coordinator. Look at row five.
Delegation of authority log
Illustrative · one protocol · one site
| Study role | 1Consent | 2Eligibility | 3Study drug | 4AE review | 5Samples | 6eCRF entry | 7Reg binder | PI sign-off |
|---|---|---|---|---|---|---|---|---|
| Principal investigatorHolds the log | Delegated | Delegated | Delegated | Delegated | Not delegated | Not delegated | Not delegated | Owner |
| Sub-investigatorPhysician, on the 1572 | Delegated | Delegated | Not delegated | Delegated | Not delegated | Not delegated | Not delegated | Signed |
| Research nurseDosing days | Delegated | Not delegated | Delegated | Not delegated | Delegated | Not delegated | Not delegated | Signed |
| CoordinatorOn the study since start-up | Delegated | Not delegated | Not delegated | Not delegated | Delegated | Delegated | Delegated | Signed |
| Coordinator, new hireTrained on the protocol this week | Trained, not delegated | Not delegated | Not delegated | Not delegated | Trained, not delegated | Trained, not delegated | Not delegated | Pending |
| Regulatory coordinatorIRB and essential records | Not delegated | Not delegated | Not delegated | Not delegated | Not delegated | Not delegated | Delegated | Signed |
Delegated and signedTrained on the protocol, not yet delegated
Row five is hired, trained and on the payroll. It still can’t consent anyone.
That record isn’t paperwork for its own sake. ICH E6(R3), the Good Clinical Practice guideline ICH adopted in January 2025 and FDA issued as final guidance that September, says the investigator should keep a record of everyone they’ve delegated trial activities to, and make sure each person is qualified and informed about the protocol.
Section 2.3.2 even covers staff provided by other parties. A contract coordinator is expected, with the same training, the same line on the log and the same investigator answering for them. So a site hire isn’t finished at the start date. It’s finished at the signature.
Clinical Research Staffing Looks Different at Sponsors, Sites and CROs
One study touches three kinds of employer. Each hires differently, and each answers for a different piece of the trial.
- Research sites21 CFR 312.60
- Hire coordinators, research nurses and regulatory coordinators, while the investigator named on the 1572 answers for running the protocol, protecting participants and getting informed consent from every one of them before any study procedure starts.
- CROsE6(R3) 3.6.6
- Hire field monitors, in-house CRAs, study start-up specialists and project managers to carry out whatever sponsor work the contract hands them, which can be one country’s monitoring or the whole trial from start to finish.
- SponsorsE6(R3) 3.6.9
- Hire clinical trial managers and clinical operations leads who oversee the whole study, outsourced pieces included.
That last row shapes sponsor hiring more than people expect. Under E6(R3) section 3.6.6 a sponsor can hand any or all of its trial work to a service provider, but the ultimate responsibility stays with the sponsor, and 3.6.9 asks for oversight of that work, subcontracted pieces included. Somebody inside has to read the CRO’s reports and push back when a site slips. That’s a hire.
CRO staffing moves with awarded studies. Start-up specialists first. Monitors next, as sites activate. Sites hire around enrollment, which doesn’t always cooperate.
Clinical Research Recruiters Should Screen for the Inspection
FDA closed 692 clinical investigator inspections in fiscal 2024, and 156 of them ended with a Form FDA 483 listing what the inspector found. The first theme in FDA’s breakdown of those observations is protocol compliance under 21 CFR 312.60.
- Consent on the wrong form, or too late.
- Participants enrolled who didn’t meet eligibility.
- Missed visits.
- Missed labs.
One line in that theme is personnel who weren’t qualified or weren’t supervised. That one starts with hiring. So a coordinator interview with us sounds less like a résumé walk and more like a study debrief.
- Which consent version did you last re-consent a participant on, and what triggered it?
- Tell me about an eligibility problem you caught before randomization.
- Which EDC have you entered data into, Medidata Rave, Veeva Vault EDC or a sponsor’s own build?
- For monitors, how much of your source review was remote, and how did you plan site visits around it?
Monitors get their own bar. Under 21 CFR 312.53(d) a sponsor has to pick a monitor qualified by training and experience, and E6(R3) now describes site monitoring done on-site or remotely next to centralised review of accumulated data. A CRA who has only worked on-site isn’t wrong for a role like that. Just a different fit.
We also ask what the person wants. A coordinator who’s tired of early morning dosing visits will leave your study halfway through if nobody asked. Ask like a friend would. Before the offer.
692
clinical investigator inspections in FDA’s fiscal 2024 data
23%
of those inspections ended with a Form FDA 483
2025
the year ICH adopted E6(R3), today’s Good Clinical Practice guideline
92%
twelve-month retention on KORE1 placements, every desk counted
Sources: FDA, FY 2024 Clinical Investigator 483 Observation Trends. ICH E6(R3), adopted 6 January 2025. KORE1 placement records.
The Clinical Trial Staffing Seats We Fill
Each card’s tag names where the seat usually sits. Plenty of CROs and sponsors hire a bit of everything.
Research site
Clinical research coordinators
The person who schedules visits, handles consent with the investigator’s team and keeps source and eCRFs in step.
Research site
Research nurses
Dosing, sample collection and participant safety checks, from nurses who’ve already worked to a protocol.
CRO
Clinical research associates
Field and in-house monitors plus start-up specialists, matched on therapeutic area, phase and remote review.
Sponsor
Clinical trial managers
The people who run a study across CROs and sites and answer for it when an auditor asks.
Seats get filled as direct hire, as contract staffing, or as contract-to-hire if seeing a coordinator through a few study visits first would help. A site staffing up for one sponsor’s study with a known end date often starts on contract, while a CRO building out a regional monitoring team for a steady book of work usually hires direct. Pipeline decides.
A few seats sit with other desks. Senior clinical operations and medical affairs searches run through our biotech recruiters, permanent pharma quality leaders through the pharmaceutical recruiters desk, and bench scientists through the scientific staffing agency. One phone number, every desk.
Common Questions
What roles does clinical research staffing cover?
It covers the site, CRO and sponsor staff who run clinical studies, from coordinators and research nurses to CRAs and clinical trial managers. KORE1 recruits for all three. Contract or direct. Protocol experience comes first in every screen.
Can a contract coordinator consent participants at our site?
Yes, once your investigator has trained them on the protocol and delegated consent to them on the log. E6(R3) section 2.3.2 covers staff provided by other parties. Same rules as your own employees. Same paperwork, too.
What’s the difference between a CRA and a CRC?
Who they work for. A clinical research coordinator works for the site and runs the study day to day. A clinical research associate works for the sponsor or CRO and checks that work against the protocol and source records. Same study, opposite sides of the table.
How soon can a new coordinator start working on a study?
On paper, the day they start. In practice they need site onboarding, protocol training and a line on the delegation log before they touch consent or study data, and every sponsor adds its own system training on top. Call early. The gap shrinks.
Do your clinical research recruiters fill CRA roles at CROs too?
Both sides. CROs hire most monitors, and sponsors hire some for oversight. We screen for therapeutic area, phase, EDC and remote monitoring either way.
Should a site hire coordinators on contract or direct?
Direct hire, if the study pipeline is steady. Contract fits one sponsor’s study with a fixed end, or an enrollment push. Contract-to-hire splits the difference, because you get to watch the coordinator work through a monitoring visit or two before you make the offer, and that tells you more than any interview will.
Do candidates need a GCP certificate?
It helps. Many sponsors want current GCP training on file. It isn’t the qualification, though, since E6(R3) asks that people be qualified by education, training and experience for whatever they’re delegated. We screen for the studies someone has actually worked.
Tell Us About the Study
Share the phase, the therapeutic area and your site activation or first-patient date. A KORE1 scientific recruiter will tell you which seats to open first and how much lead time the log needs.
Let’s Connect →Expert in finding you the right talent, right away.
Prefer LinkedIn? Message Dave Manchester
